TG Therapeutics (TGTX) Q1 2026 Earnings Transcript
Source: Motley Fool
2026-05-06 15:53:28 ET
Image source: The Motley Fool.
Wednesday, May 6, 2026 at 8:30 a.m. ET
Need a quote from a Motley Fool analyst? Email pr@fool.com
TG Therapeutics Inc.
NASDAQ: TGTX
TGTX Trading
-0.76% G/L:
$41.075 Last:
840,172 Volume:
$40.36 Open:
TGTX Latest News
June 03, 2026 07:30:00 am
TG Therapeutics Announces Positive Results from Phase 1 Trial Evaluating Subcutaneous BRIUMVI® (ublituximab-xiiy)
June 02, 2026 07:30:00 am
TG Therapeutics to Participate in the Goldman Sachs 47th Annual Healthcare Conference
June 01, 2026 07:30:00 am
TG Therapeutics Announces Publication of Post-Hoc Data from the Phase 3 ULTIMATE I & II Trials in Treatment Naive Patients with Relapsing Forms of MS Published in Frontiers in Immunology
May 28, 2026 07:30:00 am
TG Therapeutics to Participate in the Jefferies Global Healthcare Conference
TGTX Stock Data
$4,661,971,279
141,867,445
0.11%
146
N/A
Biotechnology & Life Sciences
Healthcare
US
Morrisville
